Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) saw a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 2,580,000 shares, a drop of 7.9% from the August 15th total of 2,800,000 shares. Approximately 7.1% of the shares of the company are short sold. Based on an average daily trading volume, of 223,700 shares, the days-to-cover ratio is presently 11.5 days.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. Stifel Nicolaus increased their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Truist Financial raised their price target on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Robert W. Baird boosted their price objective on Astrana Health from $54.00 to $67.00 and gave the stock an “outperform” rating in a research report on Thursday, August 15th. Finally, Baird R W raised Astrana Health to a “strong-buy” rating in a report on Thursday, May 30th. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $59.00.
View Our Latest Stock Report on ASTH
Astrana Health Trading Up 1.2 %
Astrana Health (NASDAQ:ASTH – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.39 by $0.01. The business had revenue of $486.30 million during the quarter, compared to analysts’ expectations of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The firm’s quarterly revenue was up 39.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.28 EPS. On average, equities analysts expect that Astrana Health will post 1.33 EPS for the current fiscal year.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Read More
- Five stocks we like better than Astrana Health
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Top Stocks Investing in 5G Technology
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.